THE CIALIS DIARIES

In Oct 2007, the FDA announced which the labeling for all PDE5 inhibitors, together with tadalafil, needs a more distinguished warning in the prospective threat of sudden hearing reduction as the results of publish-advertising reports of short-term deafness linked to usage of PDE5 inhibitors.[19]The dose might be improved to twenty mg or diminishe